These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15531282)

  • 1. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). 1998.
    Pedersen TR; Olsson AG; Faergeman O; Kjekshus J; Wedel H; Berg K; Wilhelmsen L; Haghfelt T; Thorgeirsson G; Pyörälä K; Miettinen T; Christophersen B; Tobert JA; Musliner TA; Cook TJ;
    Atheroscler Suppl; 2004 Oct; 5(3):99-106. PubMed ID: 15531282
    [No Abstract]   [Full Text] [Related]  

  • 2. History of the cholesterol controversy in Britain.
    Thompson GR
    QJM; 2009 Feb; 102(2):81-6. PubMed ID: 19042967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994.
    Pedersen TR; Kjekshus J; Berg K; Haghfelt T; Faergeman O; Faergeman G; Pyörälä K; Miettinen T; Wilhelmsen L; Olsson AG; Wedel H;
    Atheroscler Suppl; 2004 Oct; 5(3):81-7. PubMed ID: 15531279
    [No Abstract]   [Full Text] [Related]  

  • 4. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003.
    Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG
    Atheroscler Suppl; 2004 Oct; 5(3):115-23. PubMed ID: 15531284
    [No Abstract]   [Full Text] [Related]  

  • 5. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein analysis. Early methods in the diagnosis of atherosclerosis.
    Rosenfeld L
    Arch Pathol Lab Med; 1989 Oct; 113(10):1101-10. PubMed ID: 2679486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [4S [Scandinavian Simvastatin Survival Study]].
    Koizumi J; Yoshida I
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():410-5. PubMed ID: 11347105
    [No Abstract]   [Full Text] [Related]  

  • 9. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Scandinavian Simvastatin Survival Study: the clinical consequences].
    Larsen ML
    Rev Esp Cardiol; 1995; 48 Suppl 5():39-42. PubMed ID: 7494939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current developments in prevention of coronary heart disease].
    Windler E
    Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin: two decades in a circle.
    Kolovou GD; Katerina A; Ioannis V; Cokkinos DV
    Cardiovasc Ther; 2008; 26(2):166-78. PubMed ID: 18485137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Scandinavian Simvastatin Survival Study (4S): hasty conclusions].
    Ravnskov U
    Ugeskr Laeger; 1995 Apr; 157(15):2165-6. PubMed ID: 7652961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Real results of The Scandinavian Simvastatin Survival Study (4S)].
    Ostergaard Kristensen B
    Ugeskr Laeger; 1995 Apr; 157(15):2164-5. PubMed ID: 7652960
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW; Huff M; Oskalns R; Rudas L; Kostuk WJ
    J Heart Lung Transplant; 1995; 14(4):613-22. PubMed ID: 7578166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simvastatin vs therapeutic lifestyle changes and supplements: randomized primary prevention trial.
    Becker DJ; Gordon RY; Morris PB; Yorko J; Gordon YJ; Li M; Iqbal N
    Mayo Clin Proc; 2008 Jul; 83(7):758-64. PubMed ID: 18613992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stopping statins is bad for your health.
    Sherman FT
    Geriatrics; 2004 Nov; 59(11):8, 10. PubMed ID: 15615155
    [No Abstract]   [Full Text] [Related]  

  • 18. Coronary heart disease and cancer in twentieth-century America. An etiological dilemma.
    Grob GN
    N J Med; 2002 Oct; 99(10):29-37. PubMed ID: 12400234
    [No Abstract]   [Full Text] [Related]  

  • 19. An epidemic of coronary heart disease.
    Grimes DS
    QJM; 2012 Jun; 105(6):509-18. PubMed ID: 22262810
    [No Abstract]   [Full Text] [Related]  

  • 20. How effective is simvastatin 10 mg?
    Young J
    Br J Gen Pract; 2003 Apr; 53(489):326-7. PubMed ID: 12879839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.